Renal Effects of an Angiotensin Converting Enzyme Inhibitor in Adults With Chronic Kidney Disease of Uncertain Aetiology
A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT01624064
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 1/2
- Enrolled
- 200 participants
- Sponsor
- Registry
-
NCT01624064
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Sri Lanka
- Registry status
- Unknown status
Technical summary
Registry record NCT01624064. Randomized; quadruple masking; primary purpose treatment. Start 2012-08 (registry gives no type); primary completion 2012-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Renal Effects of an Angiotensin Converting Enzyme Inhibitor in Adults With Chronic Kidney Disease of Uncertain Aetiology
- Acronym
- CKDu
- Condition
- Renal Insufficiency, Chronic
- Intervention (Drug)
- Enalapril
- Intervention (Drug)
- Calcium Supplement
- Lead sponsor
- Ministry of Health, Sri Lanka
- Collaborator
- World Health Organization
Record details
- Record id
cardio:ct-nct01624064- Content hash
8692d47fa525f9cb425a1b02f6862f9bf8291c048c4a98affe6a8c385585cc14